Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-09

Clinical Trial Update: Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)

View source ↗

Summary

This clinical trial update describes a Duke University study evaluating immune-based biomarkers and circulating tumor cells in patients treated with immunothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: Carcinoma, Renal Cell, Carcinoma, Urothelial | Status: ACTIVE_NOT_RECRUITING